PLIANT THERAPEUTICS INC PLRX
ASignal's systematic analysis rates PLRX as Bearish.
Reflects the latest available analysis · analyzed Oct 30, 2026
The case on PLRX
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong financial health score (0.9)
- Low debt-to-equity ratio (0.20x)
- High current and quick ratios indicating liquidity cushion
- Price near 52-week low with potential mean reversion setup
- Negative MACD histogram and declining momentum
- Negative free cash flow (-$42.51M)
- Negative return on equity (-50.29%) and return on assets (-23.27%)
- Market cap below $100M indicating high risk
- Extremely limited news coverage and no Reddit sentiment
See the full verdict on PLRX
ASignal Rank (1-4), confidence score, Value / Activist / Macro grades, price targets, and the full reasoning behind the call.
How ASignal analyzes PLRX
Most investors never get a second opinion, let alone several. ASignal runs PLRX past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: value discipline, activist catalysts, and macro analysis. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.